Default: The Lancet Psychiatry

ISSN: 2215-0366

Journal Home

Journal Guideline

The Lancet Psychiatry Q1 Unclaimed

Elsevier Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The Lancet Psychiatry is a journal indexed in SJR in Psychiatry and Mental Health and Biological Psychiatry with an H index of 86. It has an SJR impact factor of 7,447 and it has a best quartile of Q1. It has an SJR impact factor of 7,447.

The Lancet Psychiatry focuses its scope in these topics and keywords: controlled, depression, randomised, thinking, symptoms, perinatal, mental, health, depressive, followup, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

The Lancet Psychiatry

7,447

SJR Impact factor

86

H Index

347

Total Docs (Last Year)

937

Total Docs (3 years)

5712

Total Refs

4496

Total Cites (3 years)

224

Citable Docs (3 years)

4,88

Cites/Doc (2 years)

16,46

Ref/Doc

Aims and Scope


controlled, depression, randomised, thinking, symptoms, perinatal, mental, health, depressive, followup, evidence, managerscannabis, injuries, intellectual, intervention, longterm, lowincome, early, disabilities, development, africa, alcohol, association, challengebaclofen, child, cohorts, comparison, conflict, countries, crosssectional, datathe,



Best articles by citations

My immortal Holmes

View more

Paternal perinatal depression in LMICs and its impact on the next generation

View more

Control of fentanyl-related substances in China

View more

Suicidal behaviour: identifying the best preventive interventions

View more

Infant autism: parents' role in ameliorating risk?

View more

Reification of the paediatric bipolar hypothesis in the USA

View more

Tears of Ishtar: women's mental health in Iraq

View more

What about treatment of smoking to improve survival and reduce depression?

View more

What about treatment of smoking to improve survival and reduce depression? -Authors' reply

View more

The loss of mourning

View more

The Future of Psychiatry Commission

View more

Variations in patterns of involuntary hospitalisation and in legal frameworks: an international comparative study

View more
SHOW MORE ARTICLES

Esketamine as a treatment for paediatric depression: questions of safety and efficacy

View more

The state of mental health care in Pakistan

View more

Screening psychiatrists: the good, the bad, and the dippy

View more

No sex please: we're scientists

View more

New Mental Health Act in Bangladesh -Authors' reply

View more

Turn on and tune in to evidence-based psychedelic research

View more

The family way

View more

The past is present: Last Year at Marienbad

View more

Trans* health: "diversity, not pathology"

View more

Intensive case management for high-risk patients with first-episode psychosis: service model and outcomes

View more

Fool's gold

View more

Mental distress and potentially modifiable social factors in post-conflict Sri Lanka - authors' response

View more

Comments

No comments ... Be the first to comment!

FAQS